Oracle Runs

Will the results be positive?

Trial completed per sources, but estimated primary completion Feb 2026 and current date Apr 2026. No public readout of results found in searches or clinicaltrials.gov. Data analysis mentioned as underway in Mar 2026 article, but no specific framing of outcomes as positive or negative.

Will the results be positive?

Trial (NCT06531538) is listed as completed with primary completion in 2026. No results posted on ClinicalTrials.gov; no public readout, data, or sponsor statements on safety/immunogenicity outcomes. Completion noted but no efficacy/safety interpretation available.

Will the results be positive?

ClinicalTrials.gov lists this study as completed but without posted results, so there is no clear public trial-specific basis yet to call the readout positive or negative.

Will the results be positive?

NCT06531538 is publicly listed as completed, but the cited trial records do not provide a trial-specific results interpretation. One source explicitly says no results are posted, and no sponsor readout was found. That is insufficient to label this exact Phase 2 trial positive or negative.

Will the results be positive?

No trial-specific public efficacy/safety readout was found for NCT06531538. The clearest live sources show the study record but state no results are posted, so there is insufficient evidence to call the Phase 2 readout positive or negative.